Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Supranuclear Palsy, Progressive 1Spinocerebellar Ataxias 1Spastic Paraplegia, Hereditary 1Obesity 1Neuromuscular Diseases 1Myotonic Dystrophy 1Myasthenia Gravis 1Muscular Dystrophy, Facioscapulohumeral 1Lambert-Eaton Myasthenic Syndrome 1Huntington Disease 1Charcot-Marie-Tooth Disease 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Interventional × Walk Test × Clear all
NCT07136844 2025-08-22

Acti-Adult

Centre Hospitalier Universitaire de Liege

Phase NA Recruiting
300 enrolled
Other

Charcot-Marie-Tooth Disease, Huntington Disease, Myasthenia Gravis, Myotonic Dystrophy, Neuromuscular Diseases, Obesity, Supranuclear Palsy, Progressive, Spastic Paraplegia, Hereditary, Lambert-Eaton Myasthenic Syndrome, Muscular Dystrophy, Facioscapulohumeral, Spinocerebellar Ataxias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡